About Hims
Hims is a publicly listed company based in San Francisco (United States) founded in 2017 by Hilary Coles, Joe Spector, Andrew Dudum, and Jack Abraham. Hims offers telehealth services and treatment options focused on mens health and wellness. Hims has raised $197 million across 5 funding rounds from investors including Redpoint Ventures, Founders Fund and Forerunner Ventures. The company has 2,107 employees. Hims has completed 8 acquisitions, including Apostrophe, Eucalyptus and Honest Health. Its chief executive, as recorded, is Andrew Dudum. Its website hims.com draws about 7 million monthly visits. Its focus areas include HealthTech, Healthcare Booking Platforms, Doctors and Telemedicine. Its competitors include Posterity Health, Opt Health and Healthemen; 2 of its 3 listed competitors have raised funding.
Company details
Hims connects customers with online healthcare services for concerns such as hair loss and sexual health. Its platform supports remote consultations and access to relevant treatment options.
- Annual Revenue$1.48 B (USD)69.33as on Dec 31, 2024
- Net Profit$126.04 M (USD)as on Dec 31, 2024
- EBITDA$85.09 M (USD)as on Dec 31, 2024
- Total Equity Funding$197M (USD)
in 5 rounds
- Latest Funding Round$850M (USD), Post-IPO
May 2025
- InvestorsRedpoint Ventures
& 9 more
- Employee Count2,107
- Investments & AcquisitionsApostrophe
& 7 more
Funding Insights of Hims
Hims has successfully raised a total of $197M across 5 strategic funding rounds. The most recent funding activity was a Post-IPO round of $850 million completed in May 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $197M
- Total Rounds 5
- Last Round Post-IPO — $850M
- First Round $7M
(Nov 2017)
- Investors Count 10
All 5 funding rounds of Hims with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May 2025 | $850M | Post-IPO | – | – | – |
| Jan 2019 | $100M | Series C | – | 8VC | |
| Jun 2018 | $50M | Series B | – | – | |
| Mar 2018 | $40M | Series B | – | – | |
| Nov 2017 | $7M | Series A | – | Thrive Capital |
10 investors in total: 10 institutional.
Investors in Hims
Hims has secured backing from 10 investors, including venture fund investors. Prominent investors backing the company include Redpoint Ventures, Founders Fund and Forerunner Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Redpoint Ventures is engaged in venture capital investments. | redpoint.com | Woodside, United States | ||
Venture capital investments in technology and defense sectors. | foundersfund.com | |||
Early-stage investments are directed toward tech startups by Forerunner Ventures. | forerunnerventures.com | San Francisco, United States | ||
Venture capital firm investing in technology, life sciences, and related sectors. | 8vc.com | |||
Growth in technology companies is supported through venture capital. | ivp.com | Menlo Park, United States | ||
Early-stage technology startups are invested in by Thrive Capital. | thrivecap.com | New York, United States | ||
Early-stage tech and life-sciences firms are funded across the US. | maverickventures.com | San Francisco, United States | ||
Early-stage investments are provided to transformative technology companies. | svangel.com | San Francisco, United States | ||
Seed-stage technology startups are invested in by Cherubic Ventures. | cherubic.com | Daan, Taiwan | ||
Early-stage venture capital investments are made by UpHonest Capital. | uphonestcapital.com | San Francisco, United States |
Investor details for Hims
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Hims
317 people are tracked at Hims (93 in leadership, 14 in board & advisors, 210 in team); the tracked headcount is 2,107.
| Name | Role | Group |
|---|---|---|
Hilary Coles | Co-Founder | Leadership |
Joe Spector | Co-Founder | Leadership |
Andrew Dudum | Founder & CEO | Leadership |
Jack Abraham | Co-Founder | Leadership |
Madeline Tung | Director Of Order Management | Leadership |
Deb Autor | Chief Policy Officer | Leadership |
Rose Martin | Director of Operations | Leadership |
Elizabeth Slaymaker | Director of Operations, GM | Leadership |
Samantha Iamurri, Ph.D | Director, R&D Quality | Leadership |
Nicholas Shockett | Senior Director, Operations | Leadership |
Jacqueline Fodor | Vp, Production | Leadership |
Soleil Teubner Boughton | Chief Legal Officer & Corporate Secretary | Leadership |
Melanie Power-Burns | Vice President, 503A Quality Operations | Leadership |
Stephanie Garcia, MBA | Vice President, Quality Systems | Leadership |
Daniel Hernandez, MS | Director of Quality | Leadership |
Patrick McInerney | Design Director, Digital | Leadership |
Josh Krueger | Senior Vice President Of Operations | Leadership |
Irene Altman Becklund | Chief Accounting Officer | Leadership |
Yemi Okupe | CFO | Leadership |
Scott Miglin | Head Compounding Pharmacist | Leadership |
297 more people are available in the full profile.
Complete people profiles for Hims
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Hims
Hims is a publicly listed company on the NYSE with ticker symbol HIMS in USA, operating in the Health services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date21 Jan 2021
- Listed onNYSE: HIMS
- Listed entityHims & Hers Health, Inc.
- Exchange sectorHealth services
- ISINUS4330001060
- Share price$29.71 (-3.04% on the day) · 2026-10-13
- Market capitalisation$6.93B
- Price to earnings69.3
- EPS (diluted, trailing year)$-0.62
- Volume (last session)9,776,810
Financials of Hims
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | $2.35B | $128.4M | $176.2M |
| 2024 | $1.48B | $126.0M | $85.1M |
| 2023 | $872.0M | -$23.6M | -$23.9M |
| 2022 | $526.9M | -$65.7M | -$61.0M |
| 2021 | $271.9M | -$107.7M | -$111.0M |
Detailed financial statements for Hims
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Hims
Hims has strategically engaged in corporate development activities, having acquired 8 companies. Notable acquisitions include Apostrophe, Eucalyptus and Honest Health.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Patient-centered healthcare solutions are delivered via a digital platform. | eucalyptus.health | Sydney, Australia | 2018 | Feb 2026 | •••• | |
Push-button blood collection devices are manufactured for medical use. | yourbiohealth.com | Medford, United States | 2007 | Dec 2025 | •••• | |
Online platform to order prescription medications or test kits | zavamed.com | London, United Kingdom | 2011 | Jun 2025 | •••• | |
At-home health testing kits and laboratory analysis are provided. | trybelabs.us | United States | 0 | Feb 2025 | •••• | |
Sterile medications are produced for hospitals and surgery centers. | medisourcerx.com | Los Alamitos, United States | 2019 | Sep 2024 | •••• | |
An online platform for dermatology diagnosis and treatment is offered. | apostrophe.com | Oakland, United States | 2012 | Jun 2021 | •••• | |
Patient empowerment, treatment, and support services are provided. | honest-health.co | London, United Kingdom | 2019 | Jun 2021 | •••• | |
Blank check firm targeting mergers across multiple sectors. | oaktreeacquisitioncorp.com | Los Angeles, United States | 2019 | Oct 2020 | •••• |
Complete acquisition details for Hims
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Hims
12 dated milestones of Hims across 9 years, from founding to its latest funding, stage changes and deals.
- Founded Hims is founded.
- Funding First funding round of $7.0M.
- Acquisition Acquires Oaktree Acquisition Corp.
- IPO Lists on the stock exchange (IPO).
- Acquisition Acquires Honest Health.
- Acquisition Acquires Apostrophe.
- Acquisition Acquires MedisourceRx.
- Acquisition Acquires Trybe Labs.
- Funding Latest funding round, Post-IPO, of $850.0M.
- Acquisition Acquires Zava.
- Acquisition Acquires YourBio Health.
- Acquisition Acquires Eucalyptus.
Competitors of Hims
Hims has 3 listed competitors in our database, 2 of them funded. They include Posterity Health, Opt Health and Healthemen.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| posterityhealth.com | 2021 | Parker, United States | $32.68M | Virtual fertility consultations and treatments for men are offered. | ||
| getopt.com | 2020 | San Francisco, United States | $6.88M | Online teleconsultation platform for men's health services is provided. | ||
| healthemen.com | 2022 | Jacksonville, United States | Subscription-based healthcare for men including medications, diet, and fitness plans. |
Detailed competitors of Hims
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Hims
The website of Hims (hims.com) receives about 7M visits a month and ranks #5,765 among all websites worldwide, #76 in Mens Health.
- Monthly visits7M
▼ 1.7% vs previous month
- Unique visitors4.3M
per month
- Global rank#5,765
among all websites
- Category rank#76
Health · Mens Health
- Bounce rate58%
- Pages per visit5.9
- Average visit2 min 14 sec
- DevicesDesktop 22% · Mobile 78%
Websites whose visitors overlap most with Hims. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
rocketrx.com | rocketrx.com | 100% | #132,450 | – | |
| forhers.com | 97% | 4.8M | #8,696 | View details | |
forhims.co.uk | forhims.co.uk | 71% | #60,659 | – | |
hers.com | hers.com | 68% | – | ||
| happyhead.com | 67% | 245.3K | #147,557 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 40 similar websites and full traffic analytics for Hims
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 40 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Digital Health & Telemedicine
3 companies that operate in the same segment as Hims (Digital Health & Telemedicine) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
An application is provided for comparing prescription drug prices nationwide. | 2011 | Santa Monica, California, United States | USD 22.21 M | USD 796.85 M | 1,063 | |
Healthcare appointments are booked online via Zocdoc's platform. | 2007 | New York, New York, United States | USD 425.97 M | USD 4.66 M | 1,365 | |
Alto Pharmacy is focused on providing convenient prescription delivery services. | 2015 | San Francisco, California, United States | USD 591.64 M | 802 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Hims
Complete news archive for Hims
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Hims
Hims was founded in 2017.
Hims is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
Andrew Dudum is the CEO of Hims, as recorded in our data. They have also founded this company.
Hims is a funded company, having raised a total of $197M across 5 funding rounds to date. The company's 1st funding round was a Series A of $7M, raised on Nov 2017.
Hims has 2,107 employees.
Annual revenue of Hims is $1.48B as on Dec 31, 2024.
Hims connects customers with online healthcare services for concerns such as hair loss and sexual health. Its platform supports remote consultations and access to relevant treatment options.
Hims's top competitors include Posterity Health, Opt Health and Healthemen.
Yes, Hims is publicly traded on NYSE under the ticker symbol HIMS.
Hims has made 8 acquisitions, including Apostrophe, Eucalyptus, and Honest Health.
Hims has 10 investors. Key investors include Redpoint Ventures, Founders Fund, Forerunner Ventures, 8VC, and IVP.
The website of Hims receives about 7 million visits a month and ranks #5,765 among all websites worldwide.